Although it is necessary for the criminal justice system to prohibit and punish conduct that is harmful to the public interest, criminalising exposure to or transmission of HIV goes against important public health principles, writes Sibusisiwe Ndlela.
Findings of two large phase III clinical trials first presented in 2020 showed a new HIV prevention injection to be highly effective. Yet, experts expect that the injection will only reach clinics in late 2022 or early 2023. If the rhetoric about bringing the urgency of COVID-19 to HIV is to mean anything, these timelines should be made shorter.
An antiretroviral injection administered every two months has been shown to be highly effective in preventing people from getting HIV in two large trials. Catherine Tomlinson asks what needs to happen before these injections become available to people in South Africa.
One of the most vibrant areas of HIV research these days is the search for new, more convenient ways to use antiretroviral medicines (ARVs) to prevent HIV infection. Elri Voigt rounds up the HIV pre-exposure prophylaxis (PrEP) research presented at the recent International AIDS Society Conference, including a biodegradable antiretroviral implant.
In what Spotlight understands to be a world-first, South Africa is on the brink of allowing pharmacists with the required permits to prescribe HIV medicines without people first having to get a script from a doctor or nurse. Catherine Tomlinson investigates how it will work and why it may be just the boost the country’s HIV response needs.
Around one in ten of the over seven million people living with HIV in South Africa are not aware that they have the virus in their bodies. One way to ensure more people are diagnosed more quickly is to make HIV self-tests more widely available. Tiyese Jeranji looks at what HIV Self Testing is, how it is done, and what government policy is on this type of HIV testing.
According to the National Department of Health HIV prevention pills are now available at 1 227 public sector facilities (36% of the total). While far from the 100% target, this is a substantial improvement on the roughly 160 facilities that provided the pills six months ago. Amy Green reports.
Voluntary Medical Male Circumcision (VMMC) has been shown to reduce the risk of female-to-male HIV transmission by 60%. But with the COVID-19 pandemic and the associated lockdown, health authorities and organisations conducting VMMC in South Africa, say the numbers of men and boys being medically circumcised have dropped dramatically. Siyabonga Kamnqa reports.
Early results from a pivotal trial of an HIV prevention injection announced by the University of the Witwatersrand researchers on Tuesday have been hailed as being a “game-changer” to turn “the tide on HIV” as it effectively reduces HIV acquisition and provides women more choices in how to protect themselves. Amy Green reports.
Antiretroviral (ARV) injections that may protect women from becoming HIV-positive, if proved to be safe and effective, will be a major step forward in the fight against the HIV pandemic. Siyabonga Kamnqa reports.
A recent announcement about a vaginal ring to prevent HIV has AIDS activists and women’s sexual and reproductive health advocates excited. But where would this ring fit in South Africa’s HIV prevention programme? Amy Green investigates.